Cargando…

P419 Galactomannan enzyme immunoassay in invasive pulmonary aspergillosis: a cross sectional study in 2021 in a New Delhi

POSTER SESSION 3, SEPTEMBER 23, 2022, 12:30 PM - 1:30 PM: OBJECTIVE: This study aims to determine the role of GM EIA in the diagnosis of IPA as per revised EORTC/MSG 2019 criteria. MATERIAL AND METHODS: A prospective cross-sectional study was performed on 87 children (from 1 to 12 years) admitted...

Descripción completa

Detalles Bibliográficos
Autor principal:	Das, Sutapa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515910/ http://dx.doi.org/10.1093/mmy/myac072.P419

Ejemplares similares

P424 Comparative analysis of Galactomannan Lateral Flow Assay, Galactomannan Enzyme Immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis
por: Hedayati, Mohammad, et al.
Publicado: (2022)

P499 A cross-sectional observational to assess the role of Bronchoalveolar lavage fluid galactomannan in the diagnosis of invasive pulmonary aspergillosis in non-neutropenic patients
por: Nomula, Gowtham Reddy, et al.
Publicado: (2022)

P428 Evaluation of Galactomannan enzyme assay in non-hematological non-neutropenic ICU admitted patients for diagnosis of Invasive Pulmonary Aspergillosis as per EORTC criteria 2019
por: Kashyap, Sanchi, et al.
Publicado: (2022)

P447 Galactomannan lateral flow assay for the diagnosis of invasive Aspergillosis among clinically suspected patients in tertiary care center, Jodhpur, Rajasthan
por: Priya, Hari, et al.
Publicado: (2022)

P412 QuicGM Aspergillus Galactomannan Ag lateral flow assay as a practical aid to diagnose invasive Aspergillosis in high-risk hematology patients
por: Aerts, Robina, et al.
Publicado: (2022)

Serum galactomannan levels in the diagnosis of invasive aspergillosis
por: Okuturlar, Yildiz, et al.
Publicado: (2015)

P436 A study to compare detection of Aspergillus galactomannan in patients with clinically suspected invasive Aspergillosis using the Lateral Flow Assay (LFA) in comparison with Enzyme Linked Immunosorbent Assay (ELISA) and identification of new risk factors as per BM-AspICU criteria
por: Padaki, Priyadarshini, et al.
Publicado: (2022)

Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients
por: Zhuang, Qidong, et al.
Publicado: (2017)

P274 COVID-associated invasive pulmonary aspergillosis (CAPA) — a case report
por: Sahoo, Asish, et al.
Publicado: (2022)

P172 First report of Aspergillus tamarii producing influenza associated invasive pulmonary Aspergillosis
por: Sahu, Monalisa, et al.
Publicado: (2022)

Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis
por: Han, Seung Beom, et al.
Publicado: (2015)

The Diagnosis of Invasive and Noninvasive Pulmonary Aspergillosis by Serum and Bronchoalveolar Lavage Fluid Galactomannan Assay
por: Zhang, Shuzhen, et al.
Publicado: (2015)

Long-Term Kinetics of Serum Galactomannan during Treatment of Complicated Invasive Pulmonary Aspergillosis
por: Tragiannidis, Athanasios, et al.
Publicado: (2023)

Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis
por: Cao, Xun-Jie, et al.
Publicado: (2020)

747. Diagnostic Performance of Bronchoalveolar Lavage Fluid Galactomannan Assay in Patients with Negative Serum Galactomannan Assay Suspected with Invasive Pulmonary Aspergillosis
por: Lim, So Yun, et al.
Publicado: (2020)

Sputum Galactomannan Has Utility in the Diagnosis of Chronic Pulmonary Aspergillosis
por: Nuh, Ali, et al.
Publicado: (2022)

Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients
por: Hsu, Li-Yang, et al.
Publicado: (2010)

Galactomannan Is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2019)

P203 Chronic pulmonary aspergillosis (CPA) in post tuberculosis sequele— aclinical experience from tertiary care
por: Gupta, Chhavi, et al.
Publicado: (2022)

P460 The Aspergillus Lateral Flow Assay for the diagnosis of invasive Aspergillosis
por: Liu, Chonglong, et al.
Publicado: (2022)

Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis
por: Román-Montes, Carla M., et al.
Publicado: (2022)

P407 Standardization of PCR for the diagnosis of invasive aspergillosis and invasive mucormycosis from blood samples
por: Rompally, Satwika, et al.
Publicado: (2022)

S10.4b Pathophysiology, diagnosis, and management of chronic pulmonary Aspergillosis
por: Izumikawa, Koichi
Publicado: (2022)

P263 Invasive Pulmonary Aspergillosis (IPA) Among Non-Intubated COVID-19 Patients—a New Age Fungal Storm
por: Raghu, Raghapriya, et al.
Publicado: (2022)

678. Galactomannan Is a Biomarker of APX001 (Fosmanogepix) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis
por: Gebremariam, Teklegiorgis, et al.
Publicado: (2019)

Performance of Aspergillus Galactomannan Lateral Flow Assay on Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Pulmonary Aspergillosis
por: Linder, Kathleen A., et al.
Publicado: (2020)

P249 Predictors of adverse outcome in sarcoidosis complicated by chronic pulmonary aspergillosis
por: Nwankwo, Lisa, et al.
Publicado: (2022)

P459 The Aspergillus lateral flow assay for the diagnosis of chronic pulmonary aspergillosis
por: Peng, Jie, et al.
Publicado: (2022)

Detection of Urinary Excreted Fungal Galactomannan-like Antigens for Diagnosis of Invasive Aspergillosis
por: Dufresne, Simon F., et al.
Publicado: (2012)

Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis
por: Lamoth, Frédéric
Publicado: (2016)

Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age
por: Mercier, Toine, et al.
Publicado: (2018)

P398 COVID-19-associated pulmonary aspergillosis: Species distribution and susceptibility profiles
por: Fakhim, Hamed, et al.
Publicado: (2022)

P155 A Mexican case series of COVID-19 - associated pulmonary aspergillosis
por: Perales-Martinez, Diana, et al.
Publicado: (2022)

P170 Life threatening hemoptysis in COVID-19 associated Pulmonary Aspergillosis (CAPA)
por: Soman, Rajeev, et al.
Publicado: (2022)

P457 Clinical correlation of beta galactomannan with culture and patient outcome in a tertiary care center in south india
por: K., Vichitra, et al.
Publicado: (2022)

Galactomannan Testing and the Incidence of Invasive Pulmonary Aspergillosis: A 10-Year Nationwide Population-Based Study in Taiwan
por: Sun, Kuo-Shao, et al.
Publicado: (2016)

S2.3d Mixed biofilm of Aspergillus fumigatus and Stenotrophomonas maltophilia: Microscopic visualization of galactosaminogalactan and galactomannan polysaccharides in the extracellular matrix
por: Valsecchi, Isabel, et al.
Publicado: (2022)

P212 Fatal invasive aspergillosis in a child with Chronic Granulomatous disease; a case report
por: Ahmadi, Bahram, et al.
Publicado: (2022)

Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosis
por: Khodavaisy, S, et al.
Publicado: (2015)

S9.1d Chronic pulmonary aspergillosis in post-TB and retreatment TB patients in Lagos, Nigeria
por: Davies, Adeyinka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7l0gdp85ojvsj2adtevmcq3hc5